PMS47 The Long Term Cost-Effectiveness of Golimumab for the Treatment of Severe, Active Ankylosing Spondylitis in Adults Who Have Responded Inadequately to Conventional Therapy

Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.433
https://www.valueinhealthjournal.com/article/S1098-3015(11)01995-4/fulltext
Title : PMS47 The Long Term Cost-Effectiveness of Golimumab for the Treatment of Severe, Active Ankylosing Spondylitis in Adults Who Have Responded Inadequately to Conventional Therapy
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01995-4&doi=10.1016/j.jval.2011.08.433
First page : A311
Section Title : Muscular-Skeletal Disorders
Open access? : No
Section Order : 406
Categories :
Tags :
Regions :
ViH Article Tags :